Pfizer kicks newly acquired meds out of Arena as part of midstage cleaning

[cafead]

via Pfizer has taken the broom to three midstage medicines from the acquisition of Arena Pharmaceuticals, deciding that etrasimod alone was worthy of the biotech’s $6.7 billion price tag.

article source